Posard Matthew L. - Insider Non-Derivative Transactions at HALOZYME THERAPEUTICS, INC. (HALO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 14, 2024, Posard Matthew L.'s relationship to HALOZYME THERAPEUTICS, INC. (HALO) is Director, and currently has 69,874 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other HALO insiders.
Data Source: SEC.
Posard Matthew L. - Insider Non-Derivative Transactions of HALO Common Stock
Posard Matthew L. - Insider Non-Derivative Transactions at HALO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 15, 2024 | Sell -- (Common Stock) | 9881 | 57.7 | 69874 |
| Aug 14, 2024 | Sell -- (Common Stock) | 10000 | 56.19 | 79755 |
| Aug 13, 2024 | Sell -- (Common Stock) | 10000 | 55.72 | 89755 |
| Jun 13, 2024 | Sell -- (Common Stock) | 10000 | 50.62 | 99755 |
| Jun 12, 2024 | Sell -- (Common Stock) | 10000 | 50.01 | 109755 |
| Apr 26, 2024 | Acquisition -- (Common Stock) | 6501 | 0 | 119755 |
| May 6, 2023 | Acquisition -- (Common Stock) | 8065 | 0 | 113254 |